US Cosmetics Compliance Guide

Short Answer

U.S. cosmetics compliance combines product classification, truthful labeling, safety responsibility and the MoCRA facility-registration and product-listing framework. A launch file should keep federal law, FDA guidance and company recommendations visibly separate.

Key Takeaways

• Classify the product before applying a cosmetics-only workflow.
• Check labeling against the FD&C Act and Fair Packaging and Labeling Act.
• Confirm whether the facility and product fall within MoCRA duties.
• Keep FDA guidance language separate from binding statutory requirements.

Who This Applies To

This guide is for brands, manufacturers, importers and responsible persons preparing to market cosmetics in the United States. It is a planning framework, not a product-specific legal opinion.

Regulatory Background

The FD&C Act and Fair Packaging and Labeling Act govern important parts of cosmetic labeling, and false or misleading labeling can make a cosmetic misbranded. [01][03][15]

MoCRA added a federal framework for cosmetic product facility registration and cosmetic product listing, subject to statutory exemptions and product-specific boundaries. [02][01]

Key Requirements

FDA labeling material identifies product identity, net quantity and the name and place of business among the information presented on a label, with required statements made conspicuous and understandable. [15][03]

• Confirm cosmetic versus drug or dual classification.
• Create a label evidence file with the exact marketed claims.
• Identify manufacturing or processing facilities in scope.
• Check the responsible person and product-listing data set.
• Record exemptions only when factual conditions are documented.

Step-by-Step Compliance Process

Start with the product and claim inventory. Separate cosmetic appearance claims from claims that may affect the structure or function of the body. Review label panels, ingredient declaration and business information. Finally document the facility, responsible person, listing and renewal questions that apply to the product and how it is marketed.

Common Mistakes

• Treating FDA registration or listing as product approval.
• Calling a product a cosmetic when claim language points to a drug classification.
• Using incomplete business information without checking the applicable labeling rules.

Practical Checklist

• Classification decision is recorded.
• Claims and label copy are versioned.
• Facility and responsible-person scope is documented.
• Listing and exemption questions have an owner.
• Official source version and review date are visible.

How EasyComply Can Help

EasyComply can separate the U.S. evidence package into product identity, formula, label, facility and submission workstreams, so a team can see which question is answered, which remains open and when a specialist review is needed.